Bone Metastasis of Urothelial Carcinoma
Asian Journal of Research and Reports in Urology,
Background: Bone metastasis of urothelial carcinoma is the third most common metastasis after the lungs and liver. Bone complications adversely affect the quality of life. They are also associated with increased mortality. The objective of this study is to describe the epidemiological, clinical and prognostic aspects of bone metastasis of urothelial carcinoma
Materials and Methods: This is a retrospective, monocentric study of 8 cases of bone metastases of urothelial carcinoma, collected from January 2018 to September 2020 at the Ibn Rochd University Hospital in Casablanca, Morocco. The analyzed data were collected on an exploitation sheet. Incomplete records were excluded from the study.
Results: The average age of our patients was 61.37 years. All the patients were male and smokers. Pain was the main calling sign and was marked in seven patients. Four patients had anemia and 50% of the patients had acute obstructive kidney disease.
CT scanning of the body was requested to all the patients and confirmed bone metastasis in seven patients with predominantly osteolytic lesions. The treatment was palliative and consisted of chemotherapy, radiotherapy or combined therapy. Among them,three patients died, two of them progressed to have new lesions and three others had stabilized lesions.
Conclusion: The presence of bone metastasis of urothelial carcinoma constitutes an unfavorable moment in the evolution of this cancer. These metastases are responsible for many complications that require multidisciplinary management.
- Urothelial carcinoma
- bone metastases
- thoracoabdominopelvic scanner
How to Cite
Lebret Thierry, Méjean Arnaud. Rare locations of metastases from urothelial carcinoma. Prog En Urol J Assoc Fr Urol Société Fr Urol. 2008;18(Suppl 7):289-97.
Morgan Rouprêt, Audenet F, Roumiguié M, Pignot G, Masson-Lecomte A, Compérat E, Houédé N, Larré S, Brunelle S, Xylinas E, Neuzillet Y, Méjean A. French recommendations of the AFU Cancer Committee - update 2020-2022: Tumors of the upper urinary excretory tract.
Hachimi Mohamed, Koutani Abdellatif, Marzouk Mohamed, El Kadiri el Hassani Bedreddine El Ghazi El Abbès, Albouzidi Abderrahmane, Elfakir Youssef, Slaoui Amine, Recommendations of good medical practice in onco-urology: Tumors of bladder, Moroccan Urological Association (AMU); 2016.
Loïc Julita, Patrice Jichlinski, Ilaria Lucca. Urothelial carcinoma of the bladder and upper urinary tract, Forum Med Switzerland. 2017;17(35):744-749.
Professor Jean-Philippe Vuillez. Secondary bone tumors, Corpus Médical- Faculté de Médecine de Grenoble ; 2003.
Morgan Rouprêt, Pignot G, Masson-Lecomte A, Compérat E, Audenet F, Roumiguié M, Houédé N, Larré S, Brunelle S, Xylinas E, Neuzillet Y, Méjean A. French recommendations of the cancer committee of the French association of urology (AFU) - Update 2020-2022 : Bladder tumors.
Siegel RL, Miller KD, Jemal A. Cancer statistics, Cancer J Clin. 2018;68:7-30.
Availablr:http://dx.doi.org / 10.3322/caac.21442
Ismaili N, Arifi S, Flechon A, El Mesbahi O, Blay JY, Droz JP, et al. Small cell cancer of the bladder: Pathology, diagnosis, treatment and prognosis Bull Cancer. 2009;96 (6):E30-E44.
Ismaili N, Amzerin M, Elmajjaoui S, Droz JP, Flechon A, Errihani H. Role of chemotherapy in the management of bladder cancer, Prog Urol. 2011;6(21):369-382.
Visser O, Adolfsson J, Rossi S, Verne J, Gatta G, Maffezzini M, et al, Incidence and survival of rare urogenital cancers in Europe. Eur J Cancer. 2012;48(4):456-64.
Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. Cancer J Clin. 2009;59:225-49.
Jacques Irani, Stéphane Bernardini, Jean-Louis Bonnal, Bruno Chauvet, Marc Colombel, Jean-Louis Davin, et al. Urothelial tumors, advances in urology. 2007;17:1065-1098.
Gremaud M, Delouche D, Monnerat C. Treatment of bone metastases with bisphosphonates, Rev Med Switzerland. 2006;2:31127.
Nicolas Amoretti, Juliette Thariat, Yasir Nouri, Pauline Foti, Olivier Hericord, Sandy Stolear, Lucia Coco, Olivier Hauger, Laurent Huwart, Pascal Boileau. Semiology of bone metastases in conventional radiology, Cancer Bulletin, French Cancer Society, John Libbey Eurotext. 2013;100 N.
Morgan Rouprêt, Tumeurs de la vessie, Bladder Tumors. What does the urologist expect from imaging? Journal of Diagnostic and Interventional Radiology. Elsevier Masson. 2012;93:314-320.
Pfister C, Roupret M, Neuzillet Y, Larré S, Pignot G, et al. CCAFU oncologic urology recommendations 2013: Bladder Tumours. Prog Urol. 2013; 23 (suppl. 2):S105-S125.
Ploeg M, Aben KK, Kiemeney LA. The current and future burden of bladder cancer worldwide. World J Urol. 2009;27:289-93.
Aapro M, Abrahamsson PA, Body JJ, et al. Guidance on the use of bisphosphonates in solid tumours : Recommendations of an international expert panel. Ann Oncol. 2008;19(3):420-32.
Henry DH, Costa L, Goldwasser F, et al. Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol. 2011;29(9):1125-32.
Abstract View: 97 times
PDF Download: 33 times